GSA CAPITAL PARTNERS LLP - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 77 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$232
-60.6%
88,923
-46.0%
0.02%
-66.1%
Q2 2023$589
+6.3%
164,596
+257.5%
0.06%
-14.5%
Q4 2022$554
-98.9%
46,039
+134.2%
0.07%
+666.7%
Q3 2020$51,00019,6590.01%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Acrospire Investment Management LLC 8,355$61,0000.04%
TOCQUEVILLE ASSET MANAGEMENT L.P. 70,000$508,0000.01%
Financial Architects, Inc 2,000$15,0000.00%
FineMark National Bank & Trust 3,473$25,0000.00%
JFS WEALTH ADVISORS, LLC 1,000$7,0000.00%
Penserra Capital Management LLC 2,540$18,0000.00%
Tower Research Capital LLC (TRC) 1,284$10,0000.00%
SIMPLEX TRADING, LLC 2,673$19,0000.00%
Plante Moran Financial Advisors, LLC 300$2,0000.00%
Cutler Group LLC / CA 2,404$17,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders